Naoko Takebe to BRCA2 Protein
This is a "connection" page, showing publications Naoko Takebe has written about BRCA2 Protein.
Connection Strength
0.296
-
Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I. JCO Precis Oncol. 2026 Jun; 10(6):e2500769.
Score: 0.243
-
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial. Oncologist. 2024 Jul 05; 29(7):638-e952.
Score: 0.053